Astrana Health
ASTH
168 hedge funds and large institutions have $813M invested in Astrana Health in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 60 reducing their positions, and 31 closing their positions.
0.26% more ownership
Funds ownership: 46.33% → 46.59% (+0.26%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $822M → $813M (-$9.03M)
5% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 60
6% less funds holding
Funds holding: 179 → 168 (-11)
35% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 31
90% less call options, than puts
Call options by funds: $313K | Put options by funds: $3.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$9.34M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.23M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.1M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$5.98M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$5.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$10.1M |
| 2 |
BlackRock
New York
|
-$5.03M |
| 3 |
Jane Street
New York
|
-$5.02M |
| 4 |
JP Morgan Chase
New York
|
-$3.11M |
| 5 |
Goldman Sachs
New York
|
-$2.83M |
ASTH Hedge Fund Activity: Q1 2025 in Review
168 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q1 2025, worth a combined $813M — down 1.1% from $822M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of ASTH and 20 opened new positions — a net loss of 11 holders — while 60 trimmed existing stakes and 57 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $9.34M. The largest seller was Loomis, Sayles & Company, exiting entirely with an estimated $10.1M sold.
- 168 institutional investors held Astrana Health (ASTH) as of Q1 2025, down from 179 in Q4 2024.
- Funds reported $813M of Astrana Health stock for Q1 2025, down 1.1% quarter-over-quarter.
- 20 funds opened new Astrana Health positions in Q1 2025 and 31 closed out, a net change of -11 holders.
- The largest Astrana Health buyer in Q1 2025 was Citadel Advisors, an estimated $9.34M added.
- The largest Astrana Health seller in Q1 2025 was Loomis, Sayles & Company, an estimated $10.1M sold.
Based on aggregated 13F filings for Q1 2025.